CannIntelligence, Author at CannIntelligence

CBD stakeholders join the parade at grand Paris cannabis festival

Written by CannIntelligence || 8th May 2019 || News analysis |

Participants at the Paris 420 Festival, organised by NORML France (National Organisation for the Reform of Marijuana Laws), were keen to raise public awareness of hemp’s various properties ...

US veterans at odds with federal agency over legalising clinical trials

Written by CannIntelligence || 8th May 2019 || News analysis |

The US Department of Veterans Affairs has opposed three CBD-related bills in Congress, leading some to wonder if the agency is looking to punish veterans who admit using medical cannabis ...

Turkey regulatory snapshot

Written by CannIntelligence || 7th May 2019 || Regulatory reports |

While the regulations governing CBD are extremely harsh, the Turkish government recently announced the launch of hemp cultivation for industrial use on a large scale ...

Sports supplement chain puts CBD products into malls across US

Written by CannIntelligence || 6th May 2019 || News analysis |

A major sports supplement chain is the latest business to bring CBD to its shelves in the US ...

Willie Nelson expands; high finance; ‘high’ burger; biosynthetic CBD

Written by CannIntelligence || 1st May 2019 || News analysis |

CBD-Intel News in Brief from the US, Canada and UK ...

Mile High sets up UK operations in Belfast, with London opening next

Written by CannIntelligence || 30th April 2019 || News analysis |

One of the largest CBD companies in the US has opened up a UK base in Northern Ireland, and is on the brink of setting up another in London ...

Importer beware: uncertainties persist in Hong Kong regulations

Written by CannIntelligence || 29th April 2019 || Regulatory reports |

While no product-specific regulation covers CBD products in Hong Kong, this report examines the rules that apply to their import, export, production and sale in the territory ...

Will FDA draw a line between other CBD products and pharmaceuticals?

Written by CannIntelligence || 29th April 2019 || News analysis |

The US FDA is to hold a public hearing on 31st May on the safety of products containing cannabis or cannabis-derived compounds ― and stakeholders will be looking for a dividing line ...

When will CBD foods be legal in the US? Don’t hold your breath

Written by CannIntelligence || 25th April 2019 || News analysis |

Could CBD soon be legally sold as a dietary supplement or food in the US? The answer depends on how quickly the federal regulatory framework on cannabis in general and CBD in particular can be eased ...

Hemp growing on the rise, but Ireland still sends abroad for medical supplies

Written by CannIntelligence || 25th April 2019 || News analysis |

Ireland’s Department of Health still won’t commit to allowing farmers to grow cannabis for medical use, two years after the health minister announced a medical cannabis access programme ...

Child health association ‘an obstacle to cannabis prescriptions,’ claims UK MP

Written by CannIntelligence || 24th April 2019 || News analysis |

A UK member of parliament has accused the president of a child healthcare organisation of lying to the parliamentary health and social care committee and dismissing the concerns of families ...

Brits back CBD for health; hemp seeds can be imported in US; German raids

Written by CannIntelligence || 23rd April 2019 || News analysis |

CBD-Intel News in Brief from the UK, US and Germany ...

How social media influencers can make fame pay in the CBD market

Written by CannIntelligence || 22nd April 2019 || News analysis |

Social media influencers are the marketing medium of the moment, and the CBD market is especially well suited to cashing in on the fame and popularity of this new form of advertising ...

New regulation kick-starts CBD and cannabis industry in Peru

Written by CannIntelligence || 19th April 2019 || News analysis |

As a potential CBD and cannabis market emerges in Peru, players from across the globe are seeing a valuable opportunity for investing in the country ...

Mexican legalisation may come with added regulation and controls

Written by CannIntelligence || 18th April 2019 || News analysis |

Mexico is well on its way to fully legalising cannabis and its derivative products, but the new government may impose stricter regulation than that left by the previous regime ...

Big Pharma ‘must not be allowed to set EU legal agenda on medical cannabis’

Written by CannIntelligence || 17th April 2019 || News analysis |

Europe desperately needs harmonised legislation on medical cannabis – but it could take five years, and Big Pharma must not be allowed to set the agenda, delegates at a conference in Brussels heard ...

Drugs commission steps in to tighten China’s CBD and hemp regulations

Written by CannIntelligence || 16th April 2019 || Regulatory reports |

China’s highest anti-drug agency, the National Narcotics Control Commission, is reported to have issued a “Notice on strengthening regulation of industrial hemp” ...

US attorney general favours bid to let states decide cannabis and CBD policy

Written by CannIntelligence || 16th April 2019 || News analysis |

US attorney general William Barr has said the current patchwork regulatory situation for CBD in the country is “intolerable” and given qualified support to an act which would allow states to decide their own policies ...

Social difficulties – how the big networks get in a tangle over CBD

Written by CannIntelligence || 15th April 2019 || News analysis |

CBD’s association with cannabis, on one level part of its marketing strength, can also be a big barrier to its acceptance. The major social networks all have as yet a rather ambiguous attitude ...

Swedish firms rein in dietary sales and health claims until courts decide

Written by CannIntelligence || 9th April 2019 || News analysis |

Several Swedish companies offering dietary supplements with CBD oil produced from industrial hemp have either stopped selling the products or significantly toned down promises of its health benefits ...

Questions in UK parliament after medical cannabis is seized at airport

Written by CannIntelligence || 9th April 2019 || News analysis |

Just two out of around 80 people prescribed medical cannabis in the UK have received products containing THC, with the rest getting CBD, the British parliament has heard ...

Federal assistance proposed for US CBD businesses with banking issues

Written by CannIntelligence || 5th April 2019 || News analysis |

Proposed new federal legislation in the US could finally help CBD businesses gain easier access to banking, a problem that has bedevilled legal cannabis-related industries since their...

US Postal Service offers guidance on mail delivery of CBD products

Written by CannIntelligence || 4th April 2019 || News analysis |

Use of the federal mail to deliver CBD products has remained a vexed question for companies in the US since the passing of the 2018 Farm Bill. Now the US Postal Service has shone some light on the...

FDA wades in with guidance on CBD – and warnings over ‘deceptive’ claims

Written by CannIntelligence || 3rd April 2019 || News analysis |

A high-level working group will explore legal pathways to market for certain CBD products, according to the US FDA – which also revealed it had sent warning letters to three companies it accused of “unfounded claims” ...

EU agriculture committee approves proposal to raise THC limit to 0.3%

Written by CannIntelligence || 3rd April 2019 || News analysis |

The European Parliament’s agriculture committee has approved proposals to put forward an amendment to the Common Agriculture Policy allowing hemp farmers to grow varieties with as much as 0.3% THC ...

Mile High accuses rival CBD firm of copyright infringement and deceit

Written by CannIntelligence || 1st April 2019 || News analysis |

Investments made by Turning Point Brands in a CBD extraction company were based on misleading information, a lawsuit filed in a US court alleges ...

Mainstream US drugstore chains announce plans to sell CBD

Written by CannIntelligence || 29th March 2019 || News analysis |

CBD products appears to be entering the mainstream of US retail. One of the largest retail pharmacy chains in the US, CVS is already selling a range of products in at least eight US states and Walgreens has...

Cannabis troubles – UK committee hears of inconsistency and confusion

Written by CannIntelligence || 26th March 2019 || News analysis |

Inconsistent quality of products purchased online, and confusion over cannabis itself, could be putting patients at risk, a group of UK MPs were told during presentations on medical cannabis and related issues ...

Cannabis is popular left, right and centre as Israeli election approaches

Written by CannIntelligence || 22nd March 2019 || News analysis |

Politicians in Israel are rarely united on any single issue, but as the much contended Israeli election draws nearer, members from across the political spectrum support the full legalisation of recreational cannabis ...

Canadian company Isodiol buys up California’s CBD Naturals

Written by CannIntelligence || 21st March 2019 || News analysis |

Isodiol International, a large-scale CBD distributor based in Vancouver, Canada, has announced that it has acquired the brand and portfolio of California-based CBD Naturals ...

All time high in sales for CBD’s new player Turning Point Brands

Written by CannIntelligence || 21st March 2019 || News analysis |

An e-cig company that has recently entered the CBD arena has reported record increases in sales and profit...

Europe’s biggest extraction plant opens in Sicily with Canadian backing

Written by CannIntelligence || 19th March 2019 || News analysis |

A new hemp extraction facility, said to be the largest in Europe, has opened in the Sicilian province of Ragusa for the production of CBD-containing products such as oils, cosmetics, and pharmaceuticals ...

There’s room yet for growth and untangling in Canada’s legal reform

Written by CannIntelligence || 18th March 2019 || News analysis |

Nearly five months after Canada legalised cannabis, its fledgling system for delivering cannabis and CBD products to consumers is still experiencing growing pains ...

CBD still in grey area but optimism for future: Israel regulatory report

Written by CannIntelligence || 15th March 2019 || Regulatory reports |

Our latest regulatory report on CBD in Israel covers the hemp plant's status, the import and export of finished product and much more. Cannabis is a dangerous drug under Israeli criminal law; the possibility of legalising industrial hemp is...

Jelly bean king Klein is hoping for the sweet smell of CBD success

Written by CannIntelligence || 13th March 2019 || News analysis |

David Klein, the man who created the iconic Jelly Belly jelly bean in the 1970s, has entered the CBD edibles market with his latest start-up Spectrum Confections, established to make CBD jelly beans ...

Reasons for optimism in a relatively new market: UK consumer survey

Written by CannIntelligence || 12th March 2019 || Market reports |

Our third consumer survey of the CBD market in the UK reveals cause for optimism, with a high degree of satisfaction and users ready to recommend CBD products and to increase their own use ...

Status and future of CBD oil in Sweden is in the lap of the courts

Written by CannIntelligence || 12th March 2019 || News analysis |

The future of CBD oil in Sweden is about to be decided as several cases inch their way through the country’s administrative courts ...

Big dollars are undeterred by red tape tangle and inconsistent enforcement

Written by CannIntelligence || 11th March 2019 || News analysis |

North American businesses are still investing millions in the CBD hemp market, despite the uncertainty generated by new legislation and clampdowns on retailers, with many US and Canadian firms acquiring nascent businesses ...

CBD to treat concussion disorders? Retired NHL players join study

Written by CannIntelligence || 8th March 2019 || News analysis |

A charity for retired ice hockey players is teaming up with one of the world’s biggest cannabis companies and a medical research body to research how CBD treatment impacts concussion-related disorders ...

French CBD users warned against buying from illicit online suppliers

Written by CannIntelligence || 7th March 2019 || News analysis |

The French Medicines Agency (Agence Nationale du Médicament, ANSM) has issued a warning to consumers against buying illicit CBD products online ...

Takeovers and investments bloom as hemp takes root across North America

Written by CannIntelligence || 5th March 2019 || News analysis |

North American companies such as Canadian firms Tilray and SOL Global, and Chicago-based Cresco Labs, are all starting or expanding their cannabidiol interests ...

State by state, US Farm Bill delivers different strokes for different folks

Written by CannIntelligence || 4th March 2019 || News analysis |

Several US states and territories are reporting changes to hemp policies following the passing of the 2018 US Farm Bill. One surprisingly positive example is Pennsylvania, which is backing growth ...

FDA jurisdiction still unchallenged – but industry presses for clarity

Written by CannIntelligence || 1st March 2019 || News analysis |

The US Food and Drug Administration is moving slowly in drawing regulatory boundaries for CBD businesses. Members of Congress have called for clarity, but the FDA says it has no plans to give cannabis derivatives the green light...

FDA sets the date for hearing on legalising hemp-derived CBD

Written by CannIntelligence || 1st March 2019 || News analysis |

The US Food and Drug Administration (FDA) has set a tentative date of sometime in April for a long-awaited public meeting to hear from stakeholders and begin a rulemaking process on legalising hemp-derived CBD, according to FDA Commissioner...

Swiss report signals ‘the beginning of the end of cannabis prohibition’

Written by CannIntelligence || 28th February 2019 || News analysis |

Growing acceptance and use of CBD in Switzerland, as demonstrated in a recent report, could eventually lead to legalisation of cannabis in the country, according to a range of experts ...

First cases of CBD shops allowed to reopen, but France remains confused

Written by CannIntelligence || 27th February 2019 || News analysis |

The French CBD market looks more promising as shops shut down last year through legal action have begun to re-open – though elsewhere in the country others are still being closed and their owners prosecuted ...

Confusion abounds in the tangle of US states’ CBD enforcement

Written by CannIntelligence || 26th February 2019 || News analysis |

Momentum in the American CBD market continues to build, but a confusing patchwork of differing interpretations by various state authorities has led to local officials starting to clamp down on retailers ...

Deal signals plans for ‘sustainable’ bio-synthesised CBD

Written by CannIntelligence || 26th February 2019 || News analysis |

The commercialisation of bio-synthesised cannabidiol could be on the horizon following the announcement by Amyris that it will be forming a new partnership to focus on “cannabinoid development”. The California-based company is best known for creating synthetic sweeteners...

High number of local brands: Czech Republic market report

Written by CannIntelligence || 22nd February 2019 || Market reports |

In our latest look at the CBD market in the Czech republic we find that CBD products are mainly sold through CBD specialist websites (both own and multi-brand stores). Unlike other European markets, pharmacies also stock a large...

Global CBD rules will get tougher, then normalise, expert predicts

Written by CannIntelligence || 20th February 2019 || News analysis |

Regulations governing hemp-derived CBD are likely to increase sharply in the near future but then tail off as the product is integrated into general regulatory frameworks for food, cosmetics and industrial products, according to a legal expert ...

LATEST ALERTS

Written by CannIntelligence || 8th May 2019 || News analysis |

Written by CannIntelligence || 8th May 2019 || News analysis |

Written by CannIntelligence || 7th May 2019 || Regulatory reports |

Written by CannIntelligence || 6th May 2019 || News analysis |

Written by CannIntelligence || 1st May 2019 || News analysis |

Written by CannIntelligence || 30th April 2019 || News analysis |

Written by CannIntelligence || 29th April 2019 || Regulatory reports |

Written by CannIntelligence || 29th April 2019 || News analysis |

Written by CannIntelligence || 25th April 2019 || News analysis |

Written by CannIntelligence || 25th April 2019 || News analysis |

Written by CannIntelligence || 24th April 2019 || News analysis |

Written by CannIntelligence || 23rd April 2019 || News analysis |

Written by CannIntelligence || 22nd April 2019 || News analysis |

Written by CannIntelligence || 19th April 2019 || News analysis |

Written by CannIntelligence || 18th April 2019 || News analysis |

Written by CannIntelligence || 17th April 2019 || News analysis |

Written by CannIntelligence || 16th April 2019 || Regulatory reports |

Written by CannIntelligence || 16th April 2019 || News analysis |

Written by CannIntelligence || 15th April 2019 || News analysis |

Written by CannIntelligence || 9th April 2019 || News analysis |

Written by CannIntelligence || 9th April 2019 || News analysis |

Written by CannIntelligence || 5th April 2019 || News analysis |

Written by CannIntelligence || 4th April 2019 || News analysis |

Written by CannIntelligence || 3rd April 2019 || News analysis |

Written by CannIntelligence || 3rd April 2019 || News analysis |

Written by CannIntelligence || 1st April 2019 || News analysis |

Written by CannIntelligence || 29th March 2019 || News analysis |

Written by CannIntelligence || 26th March 2019 || News analysis |

Written by CannIntelligence || 22nd March 2019 || News analysis |

Written by CannIntelligence || 21st March 2019 || News analysis |

Written by CannIntelligence || 21st March 2019 || News analysis |

Written by CannIntelligence || 19th March 2019 || News analysis |

Written by CannIntelligence || 18th March 2019 || News analysis |

Written by CannIntelligence || 15th March 2019 || Regulatory reports |

Written by CannIntelligence || 13th March 2019 || News analysis |

Written by CannIntelligence || 12th March 2019 || Market reports |

Written by CannIntelligence || 12th March 2019 || News analysis |

Written by CannIntelligence || 11th March 2019 || News analysis |

Written by CannIntelligence || 8th March 2019 || News analysis |

Written by CannIntelligence || 7th March 2019 || News analysis |

Written by CannIntelligence || 5th March 2019 || News analysis |

Written by CannIntelligence || 4th March 2019 || News analysis |

Written by CannIntelligence || 1st March 2019 || News analysis |

Written by CannIntelligence || 1st March 2019 || News analysis |

Written by CannIntelligence || 28th February 2019 || News analysis |

Written by CannIntelligence || 27th February 2019 || News analysis |

Written by CannIntelligence || 26th February 2019 || News analysis |

Written by CannIntelligence || 26th February 2019 || News analysis |

Written by CannIntelligence || 22nd February 2019 || Market reports |

Written by CannIntelligence || 20th February 2019 || News analysis |

Sign up to our newsletter

Start your FREE trial